|
2025
|
Invention
|
Prodrugs of treprostinil.
Provided are novel treprostinil based compounds, methods of treatment ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, pulmonary, and ... |
|
|
Invention
|
Methods of making ip-receptor agonists. Alternative processes of synthesizing ralinepag and its s... |
|
|
Invention
|
Methods of making ip-receptor agonists.
Alternative processes of synthesizing ralinepag and its ... |
|
|
G/S
|
Aircraft; Electrically powered aircraft; Vertical take-off and landing (VTOL) aircraft Research a... |
|
2024
|
Invention
|
Treprostinil prodrugs.
Provided are novel prodrugs of treprostinil, as well as methods of making... |
|
|
Invention
|
Syntheses of compounds useful for producing treprostinil.
Provided are methods of producing comp... |
|
|
Invention
|
Syntheses of compounds useful for producing treprostinil. Provided are methods of producing compo... |
|
|
Invention
|
Treprostinil derivatives and their use in pharmaceutical compositions.
Provided are treprostinil... |
|
|
Invention
|
Container and method for preserving or transporting biological materials.
A container for transp... |
|
|
Invention
|
Container and method for preserving or transporting biological materials. A container for transpo... |
|
|
Invention
|
Repair of endothelial glycocalyx. Compositions and methods relating to glycosaminoglycan componen... |
|
|
Invention
|
Repair of endothelial glycocalyx.
Compositions and methods relating to glycosaminoglycan compone... |
|
|
G/S
|
medical devices, namely lung perfusion devices used to perfuse and monitor lungs ex vivo prior to... |
|
|
Invention
|
Crystalline prostacyclin (ip) receptor agonist and uses thereof.
Described herein are crystallin... |
|
|
G/S
|
Business assistance services, namely, enrolling patients of pharmaceutical manufacturers into sup... |
|
|
Invention
|
Method of producing an oral osmotic pharmaceutical delivery system and a pharmaceutical batch pro... |
|
|
Invention
|
A method of producing an oral osmotic pharmaceutical delivery system and a pharmaceutical batch p... |
|
|
Invention
|
Controlled release pharmaceutical formulations.
Disclosed herein are drug release polymer compou... |
|
|
G/S
|
Drug delivery systems, namely, pump injectors for the subcutaneous delivery of medication |
|
|
Invention
|
Automated bioreactor system, system for automatically implementing protocol for decellularizing o... |
|
|
Invention
|
Salts of treprostinil.
Provided are novel treprostinil salts as well as methods for making trepr... |
|
|
Invention
|
Treatment for interstitial lung disease.
Methods of treating of interstitial lung disease, reduc... |
|
|
Invention
|
Treprostinil analogs and related methods of making and using.
Provided are novel treprostinil de... |
|
|
Invention
|
Treatment of pulmonary arterial hypertension. Provided are novel methods of treating pulmonary hy... |
|
|
Invention
|
Treprostinil analogs. Provided are novel treprostinil derivatives, including treprostinil prodrug... |
|
|
Invention
|
Treatment of pulmonary arterial hypertension.
Provided are novel methods of treating pulmonary h... |
|
2023
|
G/S
|
Nebulizers and inhalers for administering medication in the form of a mist inhaled into the lungs... |
|
|
Invention
|
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cel... |
|
|
Invention
|
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells. Provided are methods for ... |
|
|
Invention
|
Stable treprostinil prodrugs.
Provided are novel prodrugs of treprostinil, as well as methods of... |
|
|
Invention
|
Methods for treating pulmonary hypertension. The present disclosure provides for treating pulmona... |
|
|
Invention
|
Methods for treating pulmonary hypertension.
The present disclosure provides for treating pulmon... |
|
|
Invention
|
Prodrugs of treprostinil. Provided are novel treprostinil based compounds, methods of treatment u... |
|
|
G/S
|
refrigerated transport containers for use in the cold storage of organs for transplant nonmetal a... |
|
|
Invention
|
Process to prepare treprostinil, the active ingredient in remodulin®.
This present invention rel... |
|
|
Invention
|
Ralinepag prodrugs and uses thereof.
Described herein are ralinepag prodrugs, as well as pharmac... |
|
|
Invention
|
Ralinepag prodrugs and uses thereof. Described herein are ralinepag prodrugs, as well as pharmace... |
|
|
Invention
|
Treprostinil prodrugs. Provided are novel prodrugs of treprostinil, as well as methods of making ... |
|
|
Invention
|
Crystalline prostacyclin (ip) receptor agonist and uses thereof. Described herein are crystalline... |
|
|
Invention
|
Treprostinil iloprost combination therapy.
The disclosure relates to treatment of a disease, suc... |
|
|
Invention
|
Treprostinil iloprost combination therapy. The disclosure relates to treatment of a disease, such... |
|
|
Invention
|
Synthesis of esuberaprost prodrugs. Provided are novel prodrugs of esuberaprost and pharmaceutica... |
|
|
G/S
|
Drug delivery systems sold empty, namely, drug delivery pumps |
|
2022
|
Invention
|
Enhancement of msc immunomodulatory properties by treprostinil.
Provided are methods for treatin... |
|
|
Invention
|
Methods and compositions for improving endothelial cell barrier. Described herein are methods and... |
|
|
Invention
|
Methods and compositions for improving endothelial cell barrier.
Described herein are methods an... |
|
|
Invention
|
Treprostinil administration by inhalation.
Treprostinil can be administered using a metered dose... |
|
|
Invention
|
Systems and methods for tissue evaluation. Systems and methods are provided for evaluating a tiss... |
|
|
Invention
|
Systems and methods for tissue evaluation.
Systems and methods are provided for evaluating a tis... |
|
|
Invention
|
Parenteral formulations of treprostinil.
The present invention describes novel methods for using... |
|
|
Invention
|
Method to obtain cells from lung tissue. A method is disclosed for separating cells from a lung. ... |
|
|
Invention
|
Method to obtain cells from lung tissue.
A method is disclosed for separating cells from a lung.... |
|
|
Invention
|
System and method for maintaining organ viability.
A system comprises a fluid supply, a pressure... |
|
|
Invention
|
System and method for maintaining organ viability. A system (400) comprises a fluid supply (414),... |
|
2021
|
G/S
|
Pharmaceutical drug development services |
|
2020
|
G/S
|
Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and inters... |
|
|
G/S
|
Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension |
|
2019
|
G/S
|
Drug delivery systems |
|
2015
|
G/S
|
Pharmaceutical preparations for the treatment of heart disease, lung disease, vascular disease, a... |
|
|
G/S
|
Pharmaceutical preparations for cardiovascular conditions; pharmaceutical preparations for the tr... |
|
2013
|
G/S
|
Pharmaceutical preparations for the treatment of cancer; tumor suppressing agents. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer; tumour suppressing agents. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer; tumor suppressing agents |
|
|
G/S
|
Pharmaceutical preparations used in the treatment of cardiovascular, cardiopulmonary, pulmonary, ... |
|
2008
|
G/S
|
Cardiovascular pharmaceuticals. |
|
|
G/S
|
Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension. |
|
2007
|
G/S
|
Cardiovascular pharmaceuticals |
|
2001
|
G/S
|
Pharmaceutical preparations used in the treatment of cardiovascular diseases, pulmonary and vascu... |
|
|
G/S
|
Pharmaceutical preparations used in the treatment of cardiovascular, pulmonary and vascular disea... |
|
2000
|
G/S
|
pharmaceutical preparation used in the treatment of cardiovascular, pulmonary, and vascular disea... |
|
|
G/S
|
Pharmaceutical substances; pharmaceutical, veterinary and sanitary preparations; dietetic substan... |
|
1998
|
G/S
|
Pharmaceutical substances. |
|
|
G/S
|
Pharmaceutical substances for the treatment of pulmonary arterial hypertension (PAH), cancer, and... |
|
|
G/S
|
Pharmaceutical substances. Develop and implement innovative medical therapies. |
|
1997
|
G/S
|
pharmaceutical preparations for the treatment of chronic conditions, namely, chronic heart diseas... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of chronic conditions, namely chronic heart disease... |
